Approval · Notice of Compliance 16192 · 2014
LODALIS: Notice of Compliance 16192
Issued October 17, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16192
- Date
- October 17, 2014
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Bile acid sequestrant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LODALIS | 02432463 | Dormant |
Medicinal ingredients
- COLESEVELAM HYDROCHLORIDE 3.75 G per UNIT